RH Capital seeks to leverage venture capital as a tool to maximize public health impact along with financial returns when investing in innovations that serve the global market while including health equity directly in their investment strategy.

b-rayZ offers a revolutionary AI platform that for the first time allows personalized, flowless and sustainable diagnostics of breast cancer. The solution relies on the newest AI architectures that reveal complex patterns in medical images.

Essity joined the Tech4Eva initiative in 2022 with Kai Thornagel as a mentor to the growth stage start-ups. Essity Ventures connects the dots between innovation and expertise to revolutionize the future of health and hygiene.

Tech4Eva kicks off with a big bang on March 31st to celebrate the revealing of it's 2022 Start-up cohort!

‍124 start-ups from 30 countries have applied to take part in the second edition of Tech4Eva, the unique accelerator for FemTech start-ups in Switzerland.

With years of expertise in MedTech development, CSEM will capitalize on its wealth of knowledge to help bolster the impact of the initiative in the global FemTech community.

Metabolomic Diagnostics is a deep-tech start-up specializing in developing innovative biomarker-based diagnostic solutions for complex diseases. The current and primary focus of the company is screening for preeclampsia, as identifying women at risk of this terrible condition is an unmet clinical need.

A good treatment starts with an excellent diagnosis, which is precisely the mission of GYNTOOLS. It offers an automated device dedicated to providing excellent diagnostics for both infectious and non-infectious potential conditions of vaginitis.

Tech4Eva Conference 2021 brought together the Femtech community and shed light on the field of women's health research, focusing on topics such as: Building inefficiencies of IVF Treatment; Streamlining point of care diagnostics & trends; How host reproductive status shapes the vaginal ecosystem; Economic impact of menopause in the workplace; Trends in psychological wellbeing & women’s health and Bringing Women’s health innovation to market as well as celebrated the success of the 1st cohort.

Aspivix is a women's healthcare start-up focused on gynecology. The team focuses on reducing pain caused by procedures affecting 90 million women every year.

Yonicore is a holistic solution for pelvic floor dysfunctions. Learn about the wearable device that offers women an immediate solution, which is non-invasive.

Assembling and analyzing information about 85 organizations related to the Swiss FemTech market, including 33 companies, 15 nonprofits, and 37 investors considered by sectors, the research shed light on key features, trends, industry innovations, technologies, market segmentation, and perspective.

The first edition of Tech4Eva, a FemTech innovation platform and start-up accelerator unique in Switzerland, has proved to be a huge success. Tech4Eva is the result of a partnership launched in 2021 between Groupe Mutuel and EPFL Innovation Park to promote new technologies and solutions for women's health. Start-ups participating in the FemTech accelerator Tech4Eva raise CHF 60 million for women's health.

Boston Roadshow 2021 shed light on the field of women's health research in the United States, focusing on past policies, current practices, and the processes that will lead us to a better gender-equity future. Women are still under-represented in clinical trials compared to men. Founders also highlighted the different ways of approaching investors and the exit strategies to consider to be aligned with their investors.

The Swiss investment community is not just growing, is becoming internationally known. With more players in the space, there is more variety of investment sizes available for a wider range of companies in various sectors. This growth has created an active ground for health-tech companies successfully raising in 2020 and 2021.

On September 22nd, Tech4Eva made a great debut at London Tech Week. The third Roadshow of 2021 gathered investors, entrepreneurs, health industry leaders, and NHS experts to discuss the opportunities and key partnerships to scale femtech start-ups in the UK. 

Sexually transmitted diseases (STDs) are taboo, there is fear in getting tested and shame in contracting them and people in general know very little about them. Testmate aims to break the stigma and raise awareness while providing an accessible and easy-to-use solution.

This in-depth analysis of the trends and developments of the FemTech industry is built on data from 1550 FemTech companies, 1000 investors in this sector, and 30 laboratories and R&D centres.

Swiss-based biotech start-up, MUVON Therapeutics, is bringing cutting-edge cell therapy research to life for the regeneration of skeletal muscle tissue.

The Digital health revolution gives FemTech momentum at Tech4Eva Zurich Roadshow Corporate and health systems representatives, investors and FemTech innovators discuss investment opportunities and health trends in digital health.

Isma Hachi, PhD, Senior Manager in Life Sciences Consulting at PwC Switzerland, presents an overview of the Global top health industry issues 2021 and their impact on the FemTech sector.

Tech4Eva welcomes its partner The Embassy of Switzerland in the UK.

Tech4Eva launched the first Roadshow in Tokyo, welcoming FemTech experts, Japanese investors, corporates and start-ups for a joint discussion on the Swiss and the Japanese FemTech ecosystem. 

Tomoko Minagawa from Global Brain Corporation gives an overview of the Japanese market.

Innovative breath analysis tracker by Carbomed Medical Solutions is disrupting the fertility sector.

The inaugural program received over 100 early and growth stage start-ups applications from around the globe - 33 of those are Swiss-based - 77 of which are led by women founders.

Women of Wearables (Wow) is joining as a Program Partner of the Tech4Eva program, offering support to our participants in order to create more impact for the global Femtech community.

Tech4Eva is pleased to share the new partnership with Joyance Partners that will join the program supporting the development of the participating companies and early-stage projects. 

Tech4Eva, is thrilled to announce that Fermata will be joining as a Program partner of the program supporting the participants’ innovation and technology development by providing them visibility into Asian markets.

L’EPFL et le Groupe Mutuel s’unissent pour lancer Tech4Eva, un accélérateur de start-ups unique en Suisse et dédié aux FemTech.

Am heutigen Weltfrauentag bündeln die Groupe Mutuel und der EPFLInnovation Park ihre Kräfte, um neue Technologien für die Gesundheit der Frau zu fördern. DerEPFL Innovation Park und die Groupe Mutuel sind eine Partnerschaft eingegangen und lancierenTech4Eva, einen Start-up Accelerator im Bereich der FemTech. Eine Premiere in der Schweiz.

The EPFL and Groupe Mutuel are joining forces to launch Tech4Eva, a unique acceleration programme in Switzerland for FemTech start-ups.